Bridging Clinical Gaps: How Pharmaceutical Sciences Are Transforming Medical Practices

Article Sidebar

PDF
Published: Apr 25, 2025
DOI: https://doi.org/10.55885/jchp.v5i1.572
Keywords:
Pharmaceutical Sciences, Medical Practices, Drug Development, Personalized Medicine

Main Article Content

Widya Hastutik
Ministry of Health Polytechnic of Health Makassar, Indonesia

Abstract

This study explores how pharmaceutical sciences are transforming medical practices by bridging clinical gaps through innovative drug development. By focusing on advancements in personalized medicine, biologics, targeted therapies, and drug delivery systems, the research highlights how these innovations are improving patient outcomes, reducing healthcare costs, and enhancing treatment efficiency. The findings show a significant reduction in mortality and morbidity rates, shortened hospital stays, and improved drug adoption rates, underscoring the effectiveness of modern pharmaceutical advancements in medical practice. Through a comprehensive analysis, this study contributes to understanding how pharmaceutical sciences can address critical clinical challenges and offers insights into future medical practices.

Article Details

How to Cite
Hastutik, W. (2025). Bridging Clinical Gaps: How Pharmaceutical Sciences Are Transforming Medical Practices . Journal of Community Health Provision, 5(1), 50-60. https://doi.org/10.55885/jchp.v5i1.572
Issue
Vol. 5 No. 1 (2025): Journal of Community Health Provision
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

References

Adeniran, A. O., Asifat, J. T., Familusi, O. B., & Folorunso, S. S. (2024). Critical analysis of research methods and misperceptions of statistical analysis. International journal of innovation in management, economics and social sciences, 4(3), 29-50. https://doi.org/10.59615/ijimes.4.3.29

Alubaie, M. A., Sayed, M. Y., Alnakhli, R. E., Alshaia, F. I. N., Aldossary, S. B., Alsubaie, N. M., ... & Alahmary, M. D. A. (2024). The Efficiency and Accuracy Gains of Real-Time Health Data Integration in Healthcare Management: A Comprehensive Review of Current Practices and Future Directions. Egyptian Journal of Chemistry, 67(13), 1725-1729.

Ardiputra, M. A., Ambarwati, R., Apriyanto, A., Lingga, I. S., Elfrida, N. S. A. L., Wahyunita, S., ... & Kurniawan, G. (2025). Buku Ajar Pengantar Ilmu Farmasi:: Teori dan Perkembangannya. Jambi: PT. Sonpedia Publishing Indonesia.

Broadhurst, D. I., & Kell, D. B. (2006). Statistical strategies for avoiding false discoveries in metabolomics and related experiments. Metabolomics, 2, 171-196. https://doi.org/10.1007/s11306-006-0037-z

Brown, J. T., Bishop, J. R., & Schneiderhan, M. E. (2020). Using pharmacogenomics and therapeutic drug monitoring to guide drug selection and dosing in outpatient mental health comprehensive medication management. Mental Health Clinician, 10(4), 254-258. https://doi.org/10.9740/mhc.2020.07.254

Chen, L. F., Hoy, J., & Lewin, S. R. (2007). Ten years of highly active antiretroviral therapy for HIV infection. Medical Journal of Australia, 186(3), 146-151. https://doi.org/10.5694/j.1326-5377.2007.tb00839.x

Hamar, G. B., Rula, E. Y., Coberley, C., Pope, J. E., & Larkin, S. (2015). Long-term impact of a chronic disease management program on hospital utilization and cost in an Australian population with heart disease or diabetes. BMC health services research, 15, 1-9. https://doi.org/10.1186/s12913-015-0834-z

Hodge, K., Supabphol, S., Kumar, P., Poomipak, W., & Pisitkun, T. (2020). Recent developments in neoantigen-based cancer vaccines. Asian Pacific Journal of Allergy and Immunology, 38(2), 91-101. https://doi.org/10.12932/ap-120520-0841

Hulsen, T., Jamuar, S. S., Moody, A. R., Karnes, J. H., Varga, O., Hedensted, S., ... & McKinney, E. F. (2019). From big data to precision medicine. Frontiers in medicine, 6, 34. https://doi.org/10.3389/fmed.2019.00034

Kalaydina, R. V., Bajwa, K., Qorri, B., Decarlo, A., & Szewczuk, M. R. (2018). Recent advances in “smart” delivery systems for extended drug release in cancer therapy. International journal of nanomedicine, 4727-4745. https://doi.org/10.2147/IJN.S168053

Kandhare, P., Kurlekar, M., Deshpande, T., & Pawar, A. (2025). A Review on Revolutionizing Healthcare Technologies with AI and ML Applications in Pharmaceutical Sciences. Drugs and Drug Candidates, 4(1), 9. https://doi.org/10.3390/ddc4010009

Kolanu, N. D. (2024). CRISPR–Cas9 gene editing: curing genetic diseases by inherited epigenetic modifications. Global Medical Genetics, 11(01), 113-122. https://doi.org/10.1055/s-0044-1785234

Leopold, J. A., & Loscalzo, J. (2018). Emerging role of precision medicine in cardiovascular disease. Circulation research, 122(9), 1302-1315. https://doi.org/10.1161/CIRCRESAHA.117.310782

Li, H., Han, S., Dong, C., & Liu, Z. (2025). Advancements in conventional cancer therapy combined with immunotherapy. Oncology and Translational Medicine, 11(1), 17-28. https://doi.org/10.1097/ot9.0000000000000067

Lincetto, O., & Banerjee, A. (2020). World Prematurity Day: improving survival and quality of life for millions of babies born preterm around the world. American Journal of Physiology-Lung Cellular and Molecular Physiology, 319(5), L871-L874. https://doi.org/10.1152/ajplung.00479.2020

Low Wang, C. C., Hess, C. N., Hiatt, W. R., & Goldfine, A. B. (2016). Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus–mechanisms, management, and clinical considerations. Circulation, 133(24), 2459-2502. https://doi.org/10.1161/CIRCULATIONAHA.116.022194

Manzari, M. T., Shamay, Y., Kiguchi, H., Rosen, N., Scaltriti, M., & Heller, D. A. (2021). Targeted drug delivery strategies for precision medicines. Nature Reviews Materials, 6(4), 351-370. https://doi.org/10.1038/s41578-020-00269-6

Manzari, M. T., Shamay, Y., Kiguchi, H., Rosen, N., Scaltriti, M., & Heller, D. A. (2021). Targeted drug delivery strategies for precision medicines. Nature Reviews Materials, 6(4), 351-370. https://doi.org/10.1038/s41578-020-00269-6

Marques, L., Costa, B., Pereira, M., Silva, A., Santos, J., Saldanha, L., ... & Vale, N. (2024). Advancing precision medicine: a review of innovative in silico approaches for drug development, clinical pharmacology and personalized healthcare. Pharmaceutics, 16(3), 332. https://doi.org/10.3390/pharmaceutics16030332

Marques, L., Costa, B., Pereira, M., Silva, A., Santos, J., Saldanha, L., ... & Vale, N. (2024). Advancing precision medicine: a review of innovative in silico approaches for drug development, clinical pharmacology and personalized healthcare. Pharmaceutics, 16(3), 332. https://doi.org/10.3390/pharmaceutics16030332

Mirski, T., Mizak, L., Nakonieczna, A., & Gryko, R. (2019). Bacteriophages, phage endolysins and antimicrobial peptides-the possibilities for their common use to combat infections and in the design of new drugs. Annals of Agricultural and Environmental Medicine, 26(2). http://dx.doi.org/10.26444/aaem/105390

Mishra, D., Hubenak, J. R., & Mathur, A. B. (2013). Nanoparticle systems as tools to improve drug delivery and therapeutic efficacy. Journal of Biomedical Materials Research Part A: An Official Journal of The Society for Biomaterials, The Japanese Society for Biomaterials, and The Australian Society for Biomaterials and the Korean Society for Biomaterials, 101(12), 3646-3660. https://doi.org/10.1002/jbm.a.34642

Neumann, P. J., Sandberg, E. A., Bell, C. M., Stone, P. W., & Chapman, R. H. (2000). Are Pharmaceuticals Cost-Effective? A Review Of The Evidence: Do drug treatments give value for the money? Careful analysis can yield useful information, this study finds. Health affairs, 19(2), 92-109. https://doi.org/10.1377/hlthaff.19.2.92

Octavia, O. (2018). Pengaruh Ukuran Perusahaan Tipe Industri Dan Intensitas Research And Development Pada Pengungkapan Modal Intelektual (Doctoral dissertation, Prodi Akuntansi).

Parvin, N., Mandal, T. K., & Joo, S. W. (2024). The Impact of COVID-19 on RNA Therapeutics: A Surge in Lipid Nanoparticles and Alternative Delivery Systems. Pharmaceutics, 16(11), 1366. https://doi.org/10.3390/pharmaceutics16111366

Petrova, E. (2013). Innovation in the pharmaceutical industry: The process of drug discovery and development. In Innovation and Marketing in the Pharmaceutical Industry: Emerging Practices, Research, and Policies (pp. 19-81). New York, NY: Springer New York. https://doi.org/10.1007/978-1-4614-7801-0_2

Pharma, E. (2022). World preview 2021. Overview to, 2016.

Ruppar, T. M., Cooper, P. S., Mehr, D. R., Delgado, J. M., & Dunbar‐Jacob, J. M. (2016). Medication adherence interventions improve heart failure mortality and readmission rates: systematic review and meta‐analysis of controlled trials. Journal of the American Heart Association, 5(6), e002606. https://doi.org/10.1161/jaha.115.002606

Ruslan, H., Musfirah, N., & Rahmi, R. (2024). Assessing the Impact of Automated Dispensing Systems on Medication Safety and Workflow Efficiency in Hospital Pharmacies. Journal of Asian-African Focus in Health, 2(3), 94–102. https://doi.org/10.71435/595709

Santos-Neto, J. F., Oliveira, F. O., Hodel, K. V., Fonseca, L. M., Badaró, R., & Machado, B. A. (2021). Technological advancements in monoclonal antibodies. The Scientific World Journal, 2021(1), 6663708. https://doi.org/10.1155/2021/6663708

Schiff, D., Wen, P. Y., & Van Den Bent, M. J. (2009). Neurological adverse effects caused by cytotoxic and targeted therapies. Nature Reviews Clinical Oncology, 6(10), 596-603. https://doi.org/10.1038/nrclinonc.2009.128

Susanti, L. D., Azzahra, N. S., Ansania, A., Larasati, E. T., Triliyani, I., Khoiriyah, M., ... & Ilmi, U. (2024). Budidaya tanaman obat keluarga sebagai upaya pemberdayaan masyarakat di Desa Tanggulangin. DEDIKASI: Jurnal Pengabdian Masyarakat, 6(2), 145-160. https://doi.org/10.32332/9y0xk656

Sutanto, E. B., Christyana, T. L. P. I., Mandagie, A. K., Tjitradinata, C., & Simanjuntak, H. E. (2023). Erosi Ketimpangan Kesehatan Digital. Praxis: Jurnal Sains, Teknologi, Masyarakat dan Jejaring, 5(2), 175-187. https://doi.org/10.24167/praxis.v5i3.11114

Thacharodi, A., Singh, P., Meenatchi, R., Tawfeeq Ahmed, Z. H., Kumar, R. R., V, N., ... & Hassan, S. (2024). Revolutionizing healthcare and medicine: The impact of modern technologies for a healthier future—A comprehensive review. Health Care Science, 3(5), 329-349. https://doi.org/10.1002/hcs2.115

Thi, T. T. H., Suys, E. J., Lee, J. S., Nguyen, D. H., Park, K. D., & Truong, N. P. (2021). Lipid-based nanoparticles in the clinic and clinical trials: from cancer nanomedicine to COVID-19 vaccines. Vaccines, 9(4), 359. https://doi.org/10.3390/vaccines9040359

Tiwari, G., Tiwari, R., Sriwastawa, B., Bhati, L., Pandey, S., Pandey, P., & Bannerjee, S. K. (2012). Drug delivery systems: An updated review. International journal of pharmaceutical investigation, 2(1), 2. https://doi.org/10.4103/2230-973x.96920

Tumundo, D. G., Wiyono, W. I., & Jayanti, M. (2021). Tingkat Kepatuhan Penggunaan Obat Antihipertensi Pada Pasien Hipertensi Di Puskesmas Kema Kabupaten Minahasa Utara. Pharmacon, 10(4), 1121-1128. https://doi.org/10.35799/pha.10.2021.37409

Wang, J., Zhang, Y., Aghda, N. H., Pillai, A. R., Thakkar, R., Nokhodchi, A., & Maniruzzaman, M. (2021). Emerging 3D printing technologies for drug delivery devices: Current status and future perspective. Advanced drug delivery reviews, 174, 294-316. https://doi.org/10.1016/j.addr.2021.04.019

World Health Organization. (2023). WHO consortium on metrics and evidence for healthy ageing: report of the fourth annual meeting held virtually, 2-3 December 2020. World Health Organization.

Zhou, Q., Chen, Z. H., Cao, Y. H., & Peng, S. (2021). Clinical impact and quality of randomized controlled trials involving interventions evaluating artificial intelligence prediction tools: a systematic review. NPJ digital medicine, 4(1), 154. https://doi.org/10.1038/s41746-021-00524-2